Tavegyl 1 mg tabletter Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

tavegyl 1 mg tabletter

glaxosmithkline consumer healthcare aps - clemastinfumarat - tabletter - 1 mg

Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - influenzavirusoverfladeantigener (hæmagglutinin og neuraminidase) af stamme a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vacciner - aktiv immunisering mod h5n1-subtype af influenza a-virus. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Tavegyl 1 mg/ml injektionsvæske, opløsning Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

tavegyl 1 mg/ml injektionsvæske, opløsning

glaxosmithkline consumer healthcare aps - clemastin - injektionsvæske, opløsning - 1 mg/ml

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).

Tekturna Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

tekturna

novartis europharm ltd. - aliskiren - forhøjet blodtryk - agenter, der virker på renin-angiotensinsystemet - behandling af essentiel hypertension.

Pantecta Control Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

pantecta control

takeda gmbh - pantoprazol - gastroøsofageal tilbagesvaling - proton pumpe hæmmere - kortvarig behandling af reflukssymptomer (f.eks. halsbrand, syreregurgitation) hos voksne.

Enviage Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

enviage

novartis europharm ltd. - aliskiren - forhøjet blodtryk - agenter, der virker på renin-angiotensinsystemet - behandling af essentiel hypertension.